SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,232,133 | -4.2% | 205,643 | +119.0% | 0.47% | +19.2% |
| Q2 2023 | $4,416,165 | +30.5% | 93,921 | +16.5% | 0.39% | +31.2% |
| Q1 2023 | $3,383,864 | +12.8% | 80,645 | +2.5% | 0.30% | +15.1% |
| Q4 2022 | $2,999,520 | +20.3% | 78,645 | +23.5% | 0.26% | +8.4% |
| Q3 2022 | $2,493,000 | +16.7% | 63,665 | -3.8% | 0.24% | +25.8% |
| Q2 2022 | $2,137,000 | +92.2% | 66,165 | +96.9% | 0.19% | +126.2% |
| Q1 2022 | $1,112,000 | – | 33,610 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 475,600 | $15,362,000 | 5.31% |
| Integral Health Asset Management, LLC | 412,257 | $13,316,000 | 2.74% |
| Palo Alto Investors LP | 851,409 | $27,501,000 | 2.40% |
| Boxer Capital, LLC | 1,094,000 | $35,336,000 | 2.24% |
| DAFNA Capital Management LLC | 180,306 | $5,824,000 | 1.59% |
| Ikarian Capital, LLC | 250,000 | $8,075,000 | 1.47% |
| Bellevue Group AG | 2,973,178 | $96,034,000 | 1.36% |
| SECTOR GAMMA AS | 118,476 | $3,827,000 | 0.86% |
| Artal Group S.A. | 450,000 | $14,535,000 | 0.78% |
| Diametric Capital, LP | 19,393 | $626,000 | 0.46% |